Actively Recruiting
Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol
Led by Hillel Yaffe Medical Center · Updated on 2025-05-14
120
Participants Needed
1
Research Sites
281 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Ovarian endometriomas are cystic masses lined with endometrial tissue that contains fluid arising from a collection of menstrual debris. Ovarian endometriomas clinical manifestations includes pelvic pain, dysmenorrhea, dysfunctional uterine bleeding, and infertility. Endometriomas are most commonly treated either medically or by surgical excision. Ultrasonography (US)-guided aspiration and sclerotherapy is a new approach. Its mechanism of action is believed to be destruction of the inner epithelial lining, which is followed by inflammation and fibrosis, eventually resulting in regression of the cyst. The main advantage in this approach is the avoidance of collateral damage to the ovary.
CONDITIONS
Official Title
Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Woman with an ovarian endometrioma measuring between 25 and 100 mm
You will not qualify if you...
- Other causes of infertility including sperm disorder, ovulation disorder, uterine disorder, mechanical factor, or poor ovarian reserve
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hillel Yaffe Medical Center
Hadera, Israel
Actively Recruiting
Research Team
E
Einat Shalom-Paz, Prof
CONTACT
O
Osnat Palgi
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here